In this work, we have predominantly revealed the malignant progression promoting role of HMGB1 overexpression, meanwhile overexpressed HMGB1 also contributed to the cisplatin resistance of NSCLC in vitro and in vivo. Here, HMGB1 is linked to non-small cell lung carcinoma.